Candida mediated protection against polymicrobial sepsis
念珠菌介导的针对多种微生物败血症的保护作用
基本信息
- 批准号:10583504
- 负责人:
- 金额:$ 57.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-22 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Abdominal InfectionAnimal ModelAnti-Inflammatory AgentsAntibodiesBacteremiaCandidaCandida albicansCellsClinicalCommunicable DiseasesDataDinoprostoneDiseaseEpigenetic ProcessExposure toGastrointestinal tract structureGene ExpressionHumanImmuneImmunityInfectionIntra-abdominalInvadedKnockout MiceLeukocytesLigandsMacrophageMediatingMemoryMethodsModificationMorphogenesisMusMycosesMyeloid-derived suppressor cellsNatural ImmunityOrganismPathway interactionsPatient riskPhenotypeReportingRisk FactorsRoleS100A9 geneSecondary toSepsisSignal TransductionStaphylococcus aureusSurvivorsTestingTherapeutic immunosuppressionTrainingVirulenceWorkadaptive immunityantimicrobialcell typeclinically significantco-infectioncytokinegene complementationin vivoinhibitorinterestmicrobialmortalitynovelpathogenpathogenic funguspolymicrobial sepsispublic health relevanceresponsesecondary infectionsynergismtranslational therapeuticsvaccine access
项目摘要
Project Description
The fungal pathogen Candida albicans is the most common cause of invasive fungal infection
often originating from outgrowth and invasion from the GI tract. Invasion initially causes intra-
abdominal infections (IAI), which are often polymicrobial, and can lead to bloodstream infection
and fatal sepsis. When fungal species are involved, mortality rates increase dramatically to 50-
75% depending on patient risk factors. We recently developed an animal model of polymicrobial
fungal/bacterial intra-abdominal infection (IAI) with C. albicans (Ca) and Staphylococcus aureus
(Sa) that mimics clinical invasive disease (dissemination/sepsis) resulting in 80-100% mortality
within 96 h post-inoculation. In contrast, co-infection with the closely related C. dubliniensis (Cd)
resulted in <10% mortality. Of particular interest, survivors of Cd/Sa or Cd alone re-challenged
with a lethal co-infection (Ca/Sa) resulted in >90% survival. The protective response is sustained
long term (up to at least 60 days prior to re-challenge) and is broad-spectrum providing protection
against similarly lethal C. tropicalis/Sa and C. krusei/Sa IAI. Surprisingly, the Cd-induced
protection against lethal IAI is NOT mediated by adaptive immunity, but instead appears to be
through a mechanism of trained innate immunity (non-specific memory mediated by innate cells).
Preliminary data indicate that the trained innate response by Cd is mediated by Gr-1+ myeloid
derived suppressor cells (MDSC) that have been reported in human sepsis. The concept of
trained innate immunity mediated by MDSCs is novel for infectious disease. Accordingly, our
central hypothesis is that exposure to low virulence Candida species induce sustained broad
spectrum trained innate immune protection against lethal polymicrobial fungal-bacterial sepsis.
Mechanistically, we hypothesize that the protective response is mediated by epigenetically re-
programed MDSCs during trained innate immunity. The objective of this proposal is to define
host and microbial requirements for induction of protective trained innate immunity during
polymicrobial sepsis and investigate mechanisms involved in induction, training and effector
functions.
项目描述
真菌病原体白色念珠菌是侵入性真菌感染的最常见原因
通常起源于胃肠道的出生和入侵。入侵最初会导致内部
腹部感染(IAI),通常是多细胞性的,可能导致血液感染
和致命的败血症。当涉及真菌物种时,死亡率急剧增加到50--
75%取决于患者的危险因素。我们最近开发了一种多数菌的动物模型
真菌/细菌性腹腔内感染(IAI),白色念珠菌(CA)和金黄色葡萄球菌
(SA)模仿临床侵入性疾病(传播/败血症),导致80-100%死亡率
接种后96小时内。相反,与密切相关的都柏林梭菌(CD)共同感染
导致<10%的死亡率。特别感兴趣的是,CD/SA或CD的幸存者仅重新挑战
致命的共感染(CA/SA)导致> 90%的存活率。保护性反应持续
长期(至少在重新挑战之前至少60天),并且提供保护
针对同样致命的C. tropicalis/sa和C. krusei/sa iai。令人惊讶的是,CD引起的
防止致命IAI的保护不是由适应性免疫来介导的,而是似乎是
通过训练有素的先天免疫(由先天细胞介导的非特异性记忆)的机制。
初步数据表明,CD训练的先天反应是由GR-1+髓样介导的
在人类败血症中报道的衍生抑制细胞(MDSC)。概念
由MDSC介导的训练有素的先天免疫是用于传染病的新颖。因此,我们的
中心假设是暴露于低毒力念珠菌物种会诱导持续广泛
谱系训练有素的先天免疫保护,以防止致命性多数真菌 - 细菌败血症。
从机械上讲,我们假设保护反应是由表观遗传重新遗传的
在训练有素的先天免疫力期间,编程了MDSC。该提议的目的是定义
宿主和微生物要求在诱导保护性训练的先天免疫
多数型败血症并研究涉及诱导,训练和效应子的机制
功能。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protection against lethal sepsis following immunization with Candida species varies by isolate and inversely correlates with bone marrow tissue damage.
- DOI:10.1128/iai.00252-23
- 发表时间:2023-10-17
- 期刊:
- 影响因子:3.1
- 作者:Lilly, Elizabeth A.;Bender, Breah E.;Noverr, Mairi C.;Fidel, Paul L., Jr.
- 通讯作者:Fidel, Paul L., Jr.
Candida-induced granulocytic myeloid-derived suppressor cells are protective against polymicrobial sepsis.
- DOI:10.1128/mbio.01446-23
- 发表时间:2023-10-31
- 期刊:
- 影响因子:6.4
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL L FIDEL其他文献
PAUL L FIDEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL L FIDEL', 18)}}的其他基金
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis
HIV 相关口腔疣和念珠菌病中的口腔微生物组
- 批准号:
9331335 - 财政年份:2013
- 资助金额:
$ 57.58万 - 项目类别:
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis
HIV 相关口腔疣和念珠菌病中的口腔微生物组
- 批准号:
8906838 - 财政年份:2013
- 资助金额:
$ 57.58万 - 项目类别:
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis
HIV 相关口腔疣和念珠菌病中的口腔微生物组
- 批准号:
8485362 - 财政年份:2013
- 资助金额:
$ 57.58万 - 项目类别:
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis
HIV 相关口腔疣和念珠菌病中的口腔微生物组
- 批准号:
8739282 - 财政年份:2013
- 资助金额:
$ 57.58万 - 项目类别:
CD8 Tcells and Tissue E-cadherin in Host Defense Against Oral Candidiasis in HIV
CD8 T 细胞和组织 E-钙粘蛋白在宿主防御 HIV 口腔念珠菌病中的作用
- 批准号:
8528024 - 财政年份:2012
- 资助金额:
$ 57.58万 - 项目类别:
8th ASM Conference on Candida and Candidiasis
第八届 ASM 念珠菌和念珠菌病会议
- 批准号:
7058480 - 财政年份:2006
- 资助金额:
$ 57.58万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Ultra-thin, high strength, drug-eluting sutures for prevention of thrombosis in microvascular surgery
用于预防微血管手术中血栓形成的超薄、高强度药物洗脱缝线
- 批准号:
10672287 - 财政年份:2022
- 资助金额:
$ 57.58万 - 项目类别:
Ultra-thin, high strength, drug-eluting sutures for prevention of thrombosis in microvascular surgery
用于预防微血管手术中血栓形成的超薄、高强度药物洗脱缝线
- 批准号:
10521864 - 财政年份:2022
- 资助金额:
$ 57.58万 - 项目类别:
Candida mediated protection against polymicrobial sepsis
念珠菌介导的针对多种微生物败血症的保护作用
- 批准号:
9919513 - 财政年份:2019
- 资助金额:
$ 57.58万 - 项目类别:
Candida mediated protection against polymicrobial sepsis
念珠菌介导的针对多种微生物败血症的保护作用
- 批准号:
10366063 - 财政年份:2019
- 资助金额:
$ 57.58万 - 项目类别: